Harpera (IUO) microbiopsy tool: publication list

This blog includes links to all the published journal articles, interviews, presentations, and research and development (R&D) posters that have been written to describe studies conducted with the Harpera™ Microbiopsy Tool (IUO).

Follow the links below to access the original documents published or presented by your peers working in dermatological research, infectious skin diseases, and related fields. This page will be updated as new study papers are published, so please check back often!

Skin Cancer

1.Banan, P., et al. (2013). "Effects of exvivo skin microbiopsy on histopathologic diagnosis in melanocytic skin lesions." JAMA Dermatol 149(9): 1107-1109.

2.Prow, T.W., et al. (2013). "The opportunity for microbiopsies for skin cancer." Future Oncol9 (9): 1241-1243

3.McClenahan, P., et al. (2014). "BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib." JAMA Dermatol 150(10): 1079-1082

4. Tan, J.-M., et al.(2015). "BRAFWild-Type Melano main Situ Arising In a BRAFV600E Mutant Dysplastic Nevus." JAMA Dermatology 151(4).

5. Dermatology Research Centre, School of Medicine, The University of Queensland (March 2016), “Natural history and properties of naevi in advanced melanoma patients receiving treatment”, ACTRN 12616000272493 (ANZCTR)

6. Sobarun, P., et al. (2017). "Microbiopsy Biomarker Profiling in a Superficial Melanoma Resembling a Pigmented Basal Cell Carcinoma." JAMA Dermatol 153(4): 334-336.

7. Jain, M., et al. (2022). "Minimally invasive microbiopsy for genetic profiling of melanocyticlesions: A case series." J Am Acad Dermatol 87(4): 903-904.

Skin Disorders

8. Yamada, M., et al.(2020). "Microbiopsy-based minimally invasive skin sampling for molecular analysis is acceptable to Epidermolysis Bullosa Simplex patients where conventional diagnostic biopsy was refused." Skin Res Technol.

Inflammatory Skin Disease

9. Preis, S., et al. (2022). "Munich atopy prediction study (MAPS): protocol for a prospective birth cohort addressing clinical and molecular risk factors for a topic dermatitis in early childhood." BMJ Open12 (9):e059256.

Infectious Skin Disease

10. Tom, L.N., et al. (2016). "Skin microbiopsy for HPVDNA detection in cutaneous warts." J Eur Acad Dermatol Venereol 30(12): e216-e217.

11. Kirstein, O.D., et al. (2017). "Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani." Int J Parasitol 47(10-11): 609-616.

12. Churiso,G.,et al. (2020). "Minimally Invasive Microbiopsies as an Improved Sampling Method for the Diagnosis of Cutaneous Leishmaniasis." Open Forum Infect Dis 7(9): ofaa364.

13. Cloots, K.,et al. (2021). "Assessing L. donovani Skin Parasite Load: A Proof of Concept Study of a Microbiopsy Device in an Indian Setting." Front Cell Infect Microbiol 11: 645121.

14. Cutaneous Leishmaniasis diagnostics: microbiopsy device for minimally invasive sampling - YouTube

15. Owen, S.I., et al. (2021). "Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV- coinfected patients in India: a prospective cohort study." BMJ Open 11(4): e042519.

16. Liverpool School of Tropical Medicine (April2023). “Using BCG Vaccine to Understand Tuberculosis Infection”, NCT05820594 (ClinicalTrials.gov)

17. Van Henten, S., et al. (2024)."Evaluation of Less Invasive Sampling Tools for the Diagnosis of Cutaneous Leishmaniasis." Open Forum Infect Dis 11(4): ofae113.

General Dermatology

18. Lin, L .L. and T.W. Prow (2017). "Novel microdevices for controlled blood and skin extraction, NHMRC." Impact 2017(6): 58-60.

19. Michele Fimiani, P.R., Elisa Cinotti (2020).Technology in Practical Dermatology, Springer Cham.

20. Hadeler E, Mosca M, Hong J, Brownstone N, Liao W, Bhutani T. "Innovations in translational research in dermatology: minimally invasive methods for bio-sample acquisition." Dermatol Online J. 2021 Oct15;27(10).

Method Development

21. Lin, L.L.,et al. (2013). "Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin sampling." F1000Res 2: 120.

22. Lei,B.U.W.,et al.(2019)."Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin Analysis."JoVE (144): e58614.

Cosmeceutical Applications

23. Yamada, M., et al. (2020). "A minimally invasive clinical model to test sunscreen toxicity based on oxidative stress levels using microbiopsy and confocal microscopy-A Proof of concept study." Int J Cosmet Sci.

Be sure to visit the pages that provide more details about the Harpera skin microbiopsy tool for investigation use only (IUO):

https://www.neoteryx.com/harpera-micro-skin-biopsy

https://www.neoteryx.com/harpera-resources